Glenmark Pharma bags USFDA nod for generic version of Enstilar Foam Ruchika Sharma9 May 2022 5:30 AM GMTMumbai: Drugmaker, Glenmark Pharmaceuticals Inc., USA, today announced that it has received tentative approval from the United States Food & Drug...
FDA approves tralokinumab for moderate-to-severe atopic dermatitis Hina Zahid30 Dec 2021 4:45 PM GMTMADISON, N.J.- The U.S. Food and Drug Administration (FDA) has approved Adbryâ„¢ (tralokinumab-ldrm) for the treatment of moderate-to-severe atopic...
